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l Introduction
Since we introduced hypoxanthine measurements
in plasma for evaluating hypoxia [18], several
other investigators have documented that plasma
hypoxanthine levels in humans reflect hypoxia
[4, 6, 11, 29, 30]. It has further been established
in a series of animal experiments that the hypo-
xanthine concentration of plasma sensitively


















Fig. 1. Schematic outline of adenine^nucleotide metabol-
ism. AMP is degraded to hypoxanthine and accumulated
in hypoxia. Salvage of hypoxanthine to IMP is reduced äs
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Hypoxanthine is the breakdown product of energy
rieh nucleotides such äs ATP. In Fig. l we have
outlined some aspects of purine metabolism and
how we believe this to be affected by hypoxia:
During hypoxia there is an accelerated catabolism
of AMP to hypoxanthine, which is one way the
cells restore their intracellular energy Charge [2,
14]. Furthermore, the salvage of hypoxanthine to
inosine monophosphate (IMP) is blocked since this
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process is ATP dependant for the Formation of
phosphoribosylpyrophosphate (PRPP) [27]. The
further catabolism of hypoxanthine to urate via
xanthine is also slowed down, or even stopped
during hypoxia, since xanthine oxidase is oxygen
dependant [5]. Thus there are at least three
reasons why hypoxanthine accumulates in hypo-
xia.
There is a need for a specific biochemical indicator
of hypoxia, since lactate and base deficit (BD) are
elevated in a nurnber of conditions not associated
with hypoxia [7], Hypoxanthine is a more specific
indicator of hypoxia than these other metabolites.
It has recently been shown by THIRINGER [30],
that umbilical cord plasma hypoxanthine values
are a better indicator of intrauterine hypoxia
than BD, pH, lactate, or APGAR score. Preliminary
data from this author suggest that hypoxanthine
levels of umbilical cord plasma are better predic-
tors of neurological sequelae than these other para-
meters [30].
Elevated plasma hypoxanthine concentrations
have been found in cancer patients [23,33],how-
ever for all practical reasons elevated plasma hypo-
xanthine concentrations indicate hypoxia.
Very little data are available concerning plasma
hypoxanthine in the newborn period. In the pre-
sent study, the aim has been to compare plasma
hypoxanthine levels with BD, pH and pa02, and
further to see whether hypoxanthine levels can




Thirty two infants in our neonatal intensive care
unit (ICU) were studied. All but one were less
than one week old. One patieht was 5 months old
and was readmitted because of an infected ventri-
culo-peritoneal shunt. The gestational age of the
neonates ranged from 25—44 weeks (mean 32.2±5
weeks). The birthweights ranged from 730-4130
gram, with mean and SD 1850 ± 1000 gram. Most
of the patients suffered from respiratory distress
syndrome (RDS) (n = 21). Other diagnoses were:
Sepsis (n = 5), pneumonia (n = 3), aspiration
(n = 2) and transient tachypnea (n = 1).
2.2 Blood sampling
Fifty samples of arterial blood were drawn from
indwelling arterial umbilical catheters (mean 1.5,
ränge 1—4 blood samples from each baby). The
flrst sample (n = 32) was taken äs soon äs possible
after the infant was admitted to the unit. Thus
most of the first samples (n = 24) were taken in
the first 24 hours of life. In six neonates, the first
sample was obtained on the second day of life,
while in one neonate the first sample was obtained
on the third day of life. When more than one
sample was drawn, these were taken on consecu-
tive days. Thus all samples from the neonates
(n = 49) were obtained during the first week of
life. However, blood was not taken from patients
treated with alkali; i.e. NaHC03 or THAM. Neither
were samples taken immediately after infusion of
colloids, since such treatment can affect hypo-
xanthine values by washing out phenomenon
[l, 6], 0.6 ml of blood was taken for hypo-
xanthine analysis simultaneously with a blood gas
and acid base determination for the routine care.
The blood for hypoxanthine analysis was collected
in heparinized tubes. The erythrocytes were spun
down immediately and the plasma stored at
—20 °C until analysis. Hypoxanthine concentra-
tions in frozen plasma have been proven stable for
at least four months [4].
2.3 Analysis
Blood gases and acid base Status were determined
with a CORNING 175 automatic blood gas analysis
System. Hypoxanthine was measured äs previously
described [19]. The equipment included IL 113
blood gas equipment linked to a PERKIN EIMER
690 recorder with paper speed of 20 mm/min. The
method is based on the principle that oxygen is
consumed when hypoxanthine is converted to
urate in the presence of xanthine oxidase. By
measuring the oxygen consumption, a quantita-
tive measure of the hypoxanthine present is ob-
tained. The method does not distinguish between
hypoxanthine and xanthine, since half of the xan-
thine present is measured äs well. Since the frac-
tion of xanthine/hypoxanthine is relatively small
J. Perinat. Med. 10(1982)
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— especially in hypoxia — an error of no potential
significance is introduced when the results are
given s "hypoxanthine". The method has been
used by a series of groups [4, 6, 11, 13, 17, 31,
32] and when compared with high pressure liquid
chromatography there is an excellent correlation
(r = 0.99) between the two methods in the concen-
tration r nge from 0-187 μιηοΐ/ΐ, with a line of
identity of 0.94 [25]. With the present method,
0.2 ml of plasma is required and one analysis is
performed in 3—4 minutes.
The project was approved by the hospitals ethical
committee, and written informed consent was ob-
tained from the mothers.
3 Results
Hypoxanthine values in the 50 samples ranged
from 0-59 μιηοΐ/ΐ. The pH ranged from 7.45 to
6.62, BD from - 3 to 31 mmol/1), and pa 2 from
470 to 16 mm Hg (62.7 -2.1 kPa).
In Fig. 2 are shown the correlations between hypo-
xanthine and pH (2A), hypoxanthine and BD
(2B), and hypoxanthine and pa02 (2C) in the
first blood sample taken (n = 32). As can be seen,
there is a negative linear correlation between
hypoxanthine and pH:pH = 7.44 - 0.0123x
Hypoxanthine, r = -0.80, p < 0.001). The rela-
tion between hypoxanthine and BD is described
by the curve: BD = 0.51 χ Hypoxanthine -1.6,
r = 0.84, p < 0.001). The relation between hypo-
xanthine (Hx) and Pa02 (mm Hg) fitted best to an
exponential curve: Pa02 = 137 X 10-°0159Hx,
r = -0.64, p < 0.001).
Sequential studies of the relation between hypo-
xanthine, BD and pH were performed in some
patients without giving more Information. (Data
not shown).
μιηοΐ/l, compared to survivors whose mean maxi-
mal hypoxanthine value was 15.6 ± 8.4 μιηοΐ/ΐ
(p < 0.0005, t-test). One baby who died of cardiac
arrythmia was excluded from this calculation
(hypoxanthine = 10 μπιοΐ/ΐ).
Four out of six infants with hypoxanthine levels
greater than 25 μηιοΐ/ΐ died, while six out of 25
babies with levels lower than or equal to 25 μηιοΐ/ΐ
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Fig. 2. Linear correlation between arterial pH and plasma
hypoxanthine (A), and between BD and hypoxanthine
(B). The correlation between Pa 2 and hypoxanthine
(Hx) was best fit to an exponential curve (C).
3.1 Survival
Nine patients died. When the highest hypoxan-
thine value in each of these patients was compared
with the highest hypoxanthine value in the survi-
vors, there was a statistical significant difference
between these two groups. Those who died had a
mean maximal hypoxanthine value of 28.3 ± 14.6
3.2 Complications
Nine patients developed intracranial hemorrhage
evaluated by real time ultrasound [3]. Their mean
maximal hypoxanthine value was 21.6 ± 8.0
Mmol/l; the surviving patients without intr ventri-
c lar hemorrhage had a mean maximal hypoxan-
thine value of 13.3 ± 12.8 μιηοΐ/ΐ (p < 0.01,
J. Perinat. Med. 10 (1982)
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t-test). The first hypoxanthine values in patients
with intraventricular hemorrhages also were
significantly higher than those in patients without
(p < 0.025, t-test).
Four patients developed bronchopulmonary dys-
plasia. Their mean maximal hypoxanthine value
was 19.3 ± 12.8 μηιοΐ/ΐ compared to a mean level
of 12.8 ± 7.5 μιηοΐ/ΐ in survivors without compli-
cations (NS).
3.3 Hypoxanthine and artificial Ventilation
There was no significant correlation between
hypoxanthine values and mean airway pressure
(MAP)*, peak inspiratory pressure (PIP), or
Fi02. Patients requiring high MAP i.e. 11 cmH20
or more, had higher mean hypoxanthine concen-
tration in first blood sample (23.8 ± 10.6 μιηοΐ/ΐ)
than babies with MAP lower than 11 cmH20
(15.9 ± 12.5 Mmol/1, p < 0.05, t-test).
4 Discussion
These data demonstrate a very good correlation
between hypoxanthine and established measure-
ments of hypoxia such s pH and BD. In the
study described, the metabolic acidosis was caused
by hypoxia, since babies with acidosis from other
causes (e.g. renal problems) were not included.
The data are in good accordance with the results
from animal experiments [21, 22, 26, 31] and
show that hypoxanthine can be useful in the
hypoxia diagnosis. This will be especially useful
when acidosis is present from other causes than
hypoxia. Even if a baby is treated with alkali, the
hypoxanthine level will still give Information
about the degree of hypoxia, whilst BD will not.
From a theoretical point of view, hypoxanthine
is a more "correct" measure of hypoxia, since
this metabolite gives more direct Information on
the intracellular energy level than, for instance,
*MAP:
R X IT X PIP + (60 - R X IT) X PEEP
60
R: ventilatory rate, IT: Inspiration time, PEEP: Positive
end expiratory pressure.
lactate or BD. Since hypoxanthine is measured
easily and rdpidly by the method we have de-
scribed [19, 25], this metabolite could well be
measured routinely e.g. in the ICU.
Hypoxanthine in body fluids other than plasma
also are of interest. Hypoxanthine is elevated in
the CSF of hypoxic babies [4, 9,13,15]. Elevated
hypoxanthine levels also are found in CSF after
seizures [13, 15] and meningitis [4, 15]. Care
must therefore be exercised when interpreting
hypoxanthine values in CSF. High hypoxanthine
values have been found in meconium stained
amniotic fluid s well and this has been inter-
preted s a sign of intrauterine hypoxia [16].
Elevated oxypurine excretion in the urine by new-
borns after intrauterine hypoxia has been reported
[12], although in another study on hypoxic new-
borns no such elevation in urine was found [10].
However, in the latter investigation, it is doubtful
whether the investigators actually studied hypoxic
babies, since these authors considered all babies
with RDS to be hypoxic. In addition, they col-
lected 24 hour samples. However, to detect ele-
vated oxypurines in the urine after hypoxia, the
urine would have to be sampled at much closer
intervals, probably every 2—4 hours. In dogs,
there was a many fold increase in urinary hypo-
xanthine excretion after hemorrhagic hypotension
was relieved. The Output of elevated hypoxanthine
lasted only about 90 minutes. (SAUGSTAD un-
published data). By considering the time factor,
the measurement of the total purine pool (except
urate) in urine could be of interest in evaluating a
past hypoxic insult.
Thus, the plasma hypoxanthine concentration can
serve s a prognostic indicator, both for survival s
for complications such s intraventricular hemorr-
hage. This is in accordance with animal studies,
where it was found that the rate of plasma hypo-
xanthine elevation can serve s an indicator of
survival time in hypoxic pigs [20]. In the present
study it was found that there was a greater risk for
non-survival when plasma hypoxanthine levels ex-
ceeded 25 μπιοΐ/ΐ. In another study it was found
that 50% of the babies with plasma hypoxanthine
concentration more than 50 μηιοΐ/ΐ died, com-
pared with 33% mortality in the group with levels
lower than 50 μηιοΐ/ΐ [4].
J. Perinat. Med. 10(1982)
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There is an exponential relationship between Pa02
and hypoxanthine, although we anticipated that
the hypoxanthine level would Start to increase at a
certain level of Pa02, e.g. around 40 mm Hg. In-
stead it seems that the hypoxanthine level Starts to
increase s soon s Pa02 decreases. This finding
probably reflects an accumulation of hypoxan-
thine in the cells, s explained in the introduc-
tion, s soon s oxygen delivery to the cells is
decreased. Therefore, there may not be a definite
limit for Pa02 at which the cells may be con-
sidered hypoxic; i.e. there may be a transition
between hypoxic and non-hypoxic states. When
the Pa02 reaches a certain level, e.g. 40 mm Hg,
the hypoxanthine level increases more rapidly.
A drop in Pa02 from 100 to 90 mm Hg cor-
responds to a hypoxanthine rise in plasma of 2.9
μιηοΐ/ΐ, while a drop in Pa02 from 40 to 30 mm
Hg elicite hypoxanthine rise in plasma of 7.9
μιηοΐ/ΐ according to the present data. The cor-
respondence between the Pa02 values and the
intracellular P02 values are, of course, not known,
but would be of great interest to establish.
It recently was shown in vitro that hypoxanthine
or xanthine, with xanthine oxidase and oxygen,
forms free oxygen radicals [8]. These free radicals
have the ability to destroy cell membranes by lipid
peroxidation. They can attack granulocytes, so
that proteolytic enzymes such s elastase are rele-
ased. The combination of hypoxanthine and
100% 02 appeared to have a damaging effect on
the rat lung [24].
It has been reported that xanthine oxidase is
liberated from the liver and is found in plasma in
several diseases [28]. In sich newborns, xanthine
oxidase could well be found in plasma^ although
this has never been measured. It is possible that
the combination of elevated hypoxanthine levels,
high 02 levels plus xanthine oxidase in plasma are
factors which, in combination partly or fully are
responsible for conditions such s itraventricular
hemorrhage, retrolental fibroplasia, the acute lung
damage often seen in premature infants, and the
chronic bronchpulmonary dysplasia. Free radical
oxygen production theoretically could explain the
pathogenesis of a wide variety- of conditions in
medicine. If our speculations are correct, which
could be tested by further animal experiments,
hypoxanthine measurements could be of value
not only s an indicator of hypoxia, but also s an
indicator for the prognosis and s a guideline for
the success of treatment.
Summary
Plasma hypoxanthine concentrations have been deter-
mined in 50 samples from 32 newborn babies suffering of
hypoxia of different degree and etiology. When the hypo-
xanthine level of the first sample was correlated with pH,
base deficit or paQj, high correlation coefficients were
found. A linear relation between hypoxanthine and pH
was found according to the equation:pH = 7.44 - 0.0123x
Hypoxanthine, r = - 0.80, p < 0.001. The relation
between hypoxanthine and base deficit was described by
the curve: BD = 0.51 χ Hypoxanthine - 1.6. r = 0.84,
p < 0.001. The relation between hypoxanthine and paO2
(mm Hg) fitted best to an exponential curve:
pa02 = 137 Χ ΐ(Γ0·0159Ηχ, r = - 0.64, p < 0.001).
The patients who survived had significantly lower hypo-
xanthine levels (15.6 μηιοΐ/ΐ) than non survivors (28.3
μιηοΐ/l) (p < 0.0005), when the maximal hypoxanthine
levels were compared. Babies with hypoxanthine levels
higher than 25 μιηοΐ/ΐ had higher risk for dying than when
the level was less than 25 μπιοΐ/l (p < 0.02).
In babies with intracranial hemorrhage there was s well
higher hypoxanthine levels than0in survivors without
hemorrhage. (21.6 vs 13.3 μηιοΐ/ΐ, ρ < 0.01). Babies
requiring high mean airway pressures (11 cmH2O or
more) had higher hypoxanthine levels in the first blood
sample (23.8 μπιοΐ/ΐ) when compared with babies with
mean airway pressure lower than this level (15.9 μιηοΐ/ΐ),
p < 0.05). It is concluded that hypoxanthine is a good
indicator of hypoxia in the neonate and this metabolite
could be a valuable Supplement to the routine diagnostic
tools for hypoxia. This metabolite is probably a more
specific hypoxia measure than other established hypoxia
indicators s lactate, pH or base deficit. In addition hypo-
xanthine froni a theoretical point of view is a reflection of
the level f energyrich nucleotides s ATP since it is a
direct breakdown product of these.
It could be especially important to measure the hypo-
xanthine levels since it recently has been shown that
hypoxanthine plus xanthine oxidase and oxygen creates
oxygen free radicals which have damaging effects to the
cell. Thus the combination of hypoxanthine and oxygen
in the resuscitated asphyxiated newborn could have
adverse effects damaging the cells. We speculate whether
this creation of free radicals is responsible for several con-
ditions in neonatology with unknown pathogenesis s
intraventricular hemorrhage, retrolental fibroplasia, acute
lung damage and bronchopulmonary dysplasia etc.
Keywords: Free radicals, hypoxia, hypoxanthine, neonates, pH.
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Zusammenfassung
Plasmahypoxanthinspiegel bei Neugeborenen: Ein spezi-
fisches Anzeichen f r Hypoxie
Wir bestimmten in 50 Blutproben von 32 Neugeborenen,
die an einer Hypoxie unterschiedlichen Ausma es und
unterschiedlicher Genese litten, die Plasmahypoxanthin-
konzentrationen. Wenn man den Hypoxanthinspiegel der
ersten Probe zum pH, Basenmangel oder arteriellem pO2
setzte, ergab sich ein hoher Korrelationskoeffizient. Die
lineare Beziehung zwischen Hypoxanthin und pH wurde
durch die folgende Gleichung beschrieben: pH = 7.44
- 0.0123 χ Hypoxanthin, r = - 0.80; p < 0.001. Die Be-
ziehung zwischen Hypoxanthin und Basenmangel lie sich
beschreiben durch die Kurve: BM = 0.51 χ Hypoxanthin
- 1.6, r = 0.84; p < 0.001. Die Beziehung zwischen Hypo-
xanthin und arteriellem* pO2 (mmHg) wurde am besten
durch die exponentielle Kurve beschrieben: paC>2
= 137 X 10-°»0159Hx, r = - 0.64; p < 0.001.
Die berlebenden Neugeborenen hatten signifikant
niedrigere Hypoxanthinspiegel (15.6 μιηοΐ/ΐ) als die Nicht-
berlebenden (28.3 Mmol/1) (p < 0.0005), wenn man die
H chstspiegel miteinander verglich. Neugeborene mit
Hypoxanthinkonzentrationen, die ber 25 μιηοΐ/ΐ lagen,
hatten ein h heres Sterberisiko, als unterhalb dieses
Wertes (p < 0.02).
Bei Neugeborenen mit intrakraniellen Blutungen fanden
sich ebenfalls h here Hypoxanthinspiegel, als bei ber-
lebenden Kindern ohne Blutungen (21.6 versus 13.3
μηιοΐ/l, p < 0.01). Neugeborene, die mit mittleren Druk-
Schl sselw rter: Freie Radikale, Hypoxanthin, Hypoxie, Neugeborene, pH.
ken (11 cm H2O oder mehr) beatmet wurden, hatten
h here Hypoxanthinkonzentrationen in der ersten Blut-
probe (23.8 Mmol/1) im Vergleich mit Kindern, die mit
niedrigeren Drucken beatmet wurden (15.9 μηιοΐ/ΐ,
p < 0.05).
Wir schlie en daraus, da der Hypoxanthinspiegel ein
guter Indikator f r Hypoxie bei Neugeborenen ist und
dieser Metabolit als ein erg nzender Parameter in der
Routinediagnostik vermerkt werden kann. Dieser Meta-
bolit ist wahrscheinlich ein spezifischer Parameter f r
Hypoxie, als andere bisher verwendete Indikatoren wie
Laktat, pH oder Basenmangel. Dar ber hinaus spiegelt
Hypoxanthin von einem theoretischen Gesichtspunkt aus
den Metabolismus energiereicher Nukleotide wie ATP
wider, weil es ein direktes Abbauprodukt ist.
Es k nnte von besonderer Bedeutung sein, die Hypoxan-
thinkonzentration zu messen, weil erst k rzlich gezeigt
wurde, da Hypoxanthin und Xanthinoxidase und Sauer-
stoff freie Radikale bilden, die sch digende Effekte auf
die Zelle haben. So k nnte die Kombination von Hypo-
xanthin und Sauerstoff zellsch digende Effekte bei
wiederbelebten, asphyktischen Neugeborenen haben. Wir
erw gen, ob diese Bildung von freien Radikalen f r einige
Erscheinungen in der Neonatologie mit unbekannter
Pathogenese wie intraventrikul re Blutungen, retrolentale
Fibroplasien, akute Lungensch digung und bronchopulmo-
nale Dysplasie verantwortlich gemacht werden k nnen.
Resume
Taux d'hypoxanthine plasmatique chez les nouveaux-nes:
Un indicateur specifique dTiypoxie
Les auteurs ont determine les concentrations plasmatiques
d'hypoxanthine sur 50 echantillons en provenance de 32
nouveaux-nes en hypoxie plus ou moins grave et d'etio-
logies variees. Des coefficients de haute correlation ont
έίέ trouves lorsque le taux d'hypoxanthine du premier
echantillon correspond au pH, au deficit basique ou a k
paO2. Une relation lineaire entre hypoxanthine et pH
a ete mise en evidence conformement a l'equation:
pH = 7,44 - 0,0123 χ hypoxanthine, r=-0,80; p<0,001.
La relation entre hypoxanthine et deficit basique est
decrite par la courbe? BD = 0,51 χ hypoxanthine - 1,6,
r = 0,84; p < 0,001. La relation entre hypoxanthine et
paO2 (en mm de Hg) s'accorde au mieux avec une courve
exponentielle: paO2 = 137 X 10-0,°159Hx, r = - 0,64;
p < 0,001.
Les patients ayant sufvecu avaient des taux d'hypoxan-
thine significativernent plus bas (15,6 μπιοΐ/i) que les
autres (28,3 μπιοΐ/ΐ) (p < 0,0005), si Γόη compare les
rdsultats les plus eleves. Les nouveaux-nes ayant des taux
d'hypoxanthine superieurs a 25 μπιοΐ/ΐ ont un risque de
mortalite plus eleve que ceux dont le taux est inferieur a
25 μηιοΐ/ΐ (ρ < 0,02). De rneme les taux d'hypoxanthine
sont plus eleves chez les nourissons avec hemorragie intra-
cranienne que chez les autres (21,6 contre 13,3 μιηοΐ/ΐ,
p < 0,01). Les enfants necessitant des pressions ventila-
toires elevees (11 cm H2O ou plus) ont des taux d'hypo-
Mots-cles: Hypoxanthine, hypoxie, nouveaux-nes, pH, radicaux libres.
xanthine plus eleves dans le premier echantillon sanguin
(23,8 μιηοΐ/ΐ) que ceux des enfants necessitant des pres-
sions inferieures a ce niveau (15,9 μπιοΙ/1), ρ < 0,05.
On peut conclure que l'hypoxanthine est un bon indica-
teur dTiypoxie chez le nouveau-ne et que ce metabolite
peut entre un complement valable pour le diagnostic
dTiypoxie, en routine. Ce metabolite mesure probable-
ment ITiypoxie de fagon plus specifique que les autres
indicateurs tels que lactate, pH ou deficit basique. En
outre, d'un point de vue theorique, l'hypoxanthine est le
reflet du niveau des nucleotides riches en energie tels que
ΓΑΤΡ puisqu'il represente un produit direct de leur
degradation.
fl pourrait etre tout particulierement important de deter-
miner les taux d'hypoxanthine puisqu'il a ete recemment
mis en evidence que l'hypoxanthine en presence de
xanthine oxydase et d'oxygene provoque la formation
de radicaux libres d'oxygene qui ont des effets nuisibles
pour la celhile. C'est pourquoi Fassociation d'hypoxan-
thine et d'oxygene chez les nouveaux-n6s asphyxiques
reanimes peut avoir des effets nuisibles lesant les cellules.
Les auteurs soulevent la question de savoir si cette forma-
tion de radicaux libres n'est pas responsable d'un certain
numbre de troubles n6onataux de pathogenie inconnue
tels que Hemorragie intraventriculaire, fibrodysplasie
retrolentale, lesions pulmonaiies aig es et dysplasie
bronchopulmonake etc.
i. Perinat. Med. 10 (1982)
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